Unique ID issued by UMIN | UMIN000017016 |
---|---|
Receipt number | R000019734 |
Scientific Title | Usefulness of topical moisturizer in the treatment of skin xerosis in hemodilyzed patients |
Date of disclosure of the study information | 2015/04/02 |
Last modified on | 2016/09/09 17:22:49 |
Usefulness of topical moisturizer in the treatment of skin xerosis in hemodilyzed patients
Usefulness of topical moisturizer in the treatment of skin xerosis in hemodilyzed patients
Usefulness of topical moisturizer in the treatment of skin xerosis in hemodilyzed patients
Usefulness of topical moisturizer in the treatment of skin xerosis in hemodilyzed patients
Japan |
Skin xerosis in hemodialyzed patient
Nephrology | Dermatology |
Others
NO
To evaluate the usefulness of the skin care with topical moisturizer in the treatment of skin xerosis in hemodialyzed patients.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
The water content of the stratum corneum
Efficacy (Skin xerosis, pruritus, etc. ), Safety
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Base treatment
Base treatment + moisturizer
20 | years-old | <= |
80 | years-old | >= |
Male and Female
(1) Chronic renal failure patients who regularly receive hemodialysis two or three times a week and are not likely to have a serious treatment change or acute symptoms during the study period.
(2) Patients with skin xerosis
(3) Patients with pruritus at time of signing the consent form
(4) Patients who signed informed consent.
(5) Patients aged 20 to 80 years at time of signing the consent form.
(6) Patients of either sex.
(1) Patients who received heparinoid- or urea -containing drugs within two weeks before signing the consent form.
(2) Patients with/ with the past of extensive complications of the skin (burn, psoriasis etc.).
(3) Patients with allergy to heparinoid.
(4) Patients with hemorrhagic blood disease (hemophilia, thrombocytopenia, purpura etc.).
(5) Patients who are expected a few bleeding causes a serious result.
(6) Patients who participated in other clinical study within 4 months before starting study.
(7) Patients who are unsuitable to the study at the investigator's discretion.
12
1st name | |
Middle name | |
Last name | Kazumasa Hashimoto |
Nippon Medical School
The Kidney Disease Clinic of NMS
Asaka Building, 1-7-15 Honkomagome, Bunkyo-ku, Tokyo, Japan
03-3821-1601
k-hashi@nms.ac.jp
1st name | |
Middle name | |
Last name | Kazumasa Hashimoto |
Nippon Medical School
The Kidney Disease Clinic of NMS
Asaka Building, 1-7-15 Honkomagome, Bunkyo-ku, Tokyo, Japan
03-3821-1601
k-hashi@nms.ac.jp
The Kidney Disease Clinic of Nippon Medical School
Maruho Co.,Ltd.
Profit organization
Japan
None
None
NO
日本医科大学 腎クリニック (東京都)
2015 | Year | 04 | Month | 02 | Day |
Unpublished
Completed
2014 | Year | 12 | Month | 19 | Day |
2015 | Year | 05 | Month | 01 | Day |
2016 | Year | 01 | Month | 31 | Day |
2015 | Year | 04 | Month | 02 | Day |
2016 | Year | 09 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019734